What were some of your most satisfying successes of the past year, and why? Advising on the J&J spin-off, which was transformative for our client. Many large pharma players are spinning off their consumer health businesses, and we’ve established ourselves as go-to advisors in this space. In addition to advising J&J, we’ve advised GSK and Merck on their spin-offs.

Also advising Nielsen on its sale. Nielsen has been broken apart and put together multiple times over the course of its history and it has been rewarding to have been part of two transformational projects in my career.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]